Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MeliaPharm is a German specialty pharmaceutical company headquartered in Frankfurt am Main, specializing in the medical cannabis sector. The company focuses on the procurement, quality assurance, and distribution of pharmaceutical-grade cannabis flowers and cannabinoid extracts. Operating under stringent EU-GMP guidelines, MeliaPharm ensures that its products meet the high standards required for medicinal use in the European market. Their portfolio is designed to support healthcare professionals and pharmacies in providing standardized cannabinoid therapies to patients with chronic and severe conditions. By bridging the gap between international cultivators and local pharmacies, MeliaPharm plays a key role in the German medical cannabis supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Meliapharm.